Clinical Trials Directory

Trials / Completed

CompletedNCT01533688

Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients

Efficacy and Tolerability of Various Bowel Preparations in Diabetic Patients: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
212 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Poor bowel preparation and patient intolerance of the procedure are the most important factors contributing to the limitation of colonoscopy. Inadequate bowel cleansing results in incomplete testing, increased potential to miss lesions, increased cost, and decreased patient satisfaction. The investigators hope to gain better insight into which bowel preparation works best in diabetic patients and hence would increase patient satisfaction, tolerability of the bowel preparation and decrease overall costs. The investigators will investigate which bowel preparation for colonoscopy will work optimally in diabetic patients using three different regimens.

Conditions

Interventions

TypeNameDescription
DRUGGolytely (polyethylene glycol electrolyte lavage solution) and placebo4 liters of polyethylene glycol electrolyte lavage solution (PEG-ELS-(GoLytely))+ placebo given the evening prior to the colonoscopy
DRUGsplit dose of Golytely (polyethylene glycol electrolyte lavage solution) + placebosplit dose (2 L taken the evening before and 2 L taken the morning of the colonoscopy) of 4 liters Golytely + placebo
DRUGsplit dose of Golytely (polyethylene glycol electrolyte lavage solution) and bisacodylsplit dose ( 2 L taken the evening before and 2 L taken the morning of the colonoscopy) of 4 liters of Golytely + bisacodyl 10 mg

Timeline

Start date
2011-10-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2012-02-15
Last updated
2018-09-07
Results posted
2018-08-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01533688. Inclusion in this directory is not an endorsement.